Journal Article

Elevated NCOR1 disrupts PPARα/γ signaling in prostate cancer and forms a targetable epigenetic lesion

Sebastiano Battaglia, Orla Maguire, James L. Thorne, Laura B. Hornung, Craig L. Doig, Song Liu, Lara E. Sucheston, Anna Bianchi, Farhat L. Khanim, Lyndon M. Gommersall, Henry S.O. Coulter, Serena Rakha, Ian Giddings, Laura P. O'Neill, Colin S. Cooper, Christopher J. McCabe, Christopher M. Bunce and Moray J. Campbell

in Carcinogenesis

Volume 31, issue 9, pages 1650-1660
Published in print September 2010 | ISSN: 0143-3334
Published online May 2010 | e-ISSN: 1460-2180 | DOI:
Elevated NCOR1 disrupts PPARα/γ signaling in prostate cancer and forms a targetable epigenetic lesion

More Like This

Show all results sharing this subject:

  • Clinical Cytogenetics and Molecular Genetics


Show Summary Details


The loss of anti-proliferative responsiveness in prostate cancer cell lines toward ligands for vitamin D receptor, retinoic acid receptors/retinoid X receptors and peroxisome proliferator activated receptor (PPAR)α/γ may entail underlying epigenetic events, as ligand insensitivity reflects significantly altered messenger RNA expression of corepressors and histone-modifying enzymes. Expression patterns were dependent on phases of the cell cycle and associated with repressed basal gene expression of vitamin D receptor and PPARα/γ target genes, for example CDKN1A [encodes p21(waf1/cip1)]. Elevated nuclear corepressor 1 (NCOR1) and nuclear corepressor 2/silencing mediator of retinoic acid and thyroid hormone receptor protein levels were detected in prostate cancer cell lines compared with non-malignant counterparts. Knockdown of the corepressor NCOR1 significantly elevated basal expression of a cohort of target genes, including CDKN1A. Both chemical [histone deacetylases inhibitor (HDACi)] and NCOR1 knockdown targeting enhanced anti-proliferative sensitivity toward PPARα/γ ligands in prostate cancer cell lines. Pursuing PPARα/γ signaling, microarray approaches were undertaken to identify pathways and genes regulated uniquely by a combination of PPARα/γ activation and HDAC inhibition. Again, HDACi and knockdown approaches demonstrated that elevated NCOR1 expression and activity distorted PPARα/γ gene targets centered on, for example cell cycle control, including CDKN1A and TGFBRAP1. Quantitative real time polymerase chain reaction validation and chromatin immunoprecipitation assays both confirmed that elevated NCOR1 disrupted the ability of PPARα/γ to regulate key target genes (CDKN1A and TGFBRAP1). Interrogation of these relationships in prostate cancer samples using principal component and partial correlation analyses established significant interdependent relationships between NCOR1–PPARα/γ and representative target genes, independently of androgen receptor expression. Therefore, we conclude that elevated NCOR1 distorts the actions of PPARα/γ selectively and generates a potential epigenetic lesion with diagnostic and prognostic significance.

Journal Article.  7135 words.  Illustrated.

Subjects: Clinical Cytogenetics and Molecular Genetics

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.